William A. Fischer-Ii

Intensive Care Medicine
601 N Caroline St
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors.

PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 05, 2020
Showing 1-1 of 1

Last Updated: 09/26/2026